These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31325612)

  • 1. Superficial candidosis by Candida duobushaemulonii: An emerging microorganism.
    Frías-De-León MG; Martínez-Herrera E; Acosta-Altamirano G; Arenas R; Rodríguez-Cerdeira C
    Infect Genet Evol; 2019 Nov; 75():103960. PubMed ID: 31325612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candida haemulonii complex: species identification and antifungal susceptibility profiles of clinical isolates from Brazil.
    Ramos LS; Figueiredo-Carvalho MH; Barbedo LS; Ziccardi M; Chaves AL; Zancopé-Oliveira RM; Pinto MR; Sgarbi DB; Dornelas-Ribeiro M; Branquinha MH; Santos AL
    J Antimicrob Chemother; 2015 Jan; 70(1):111-5. PubMed ID: 25134720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidrug-Resistant Candida auris Misidentified as Candida haemulonii: Characterization by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and DNA Sequencing and Its Antifungal Susceptibility Profile Variability by Vitek 2, CLSI Broth Microdilution, and Etest Method.
    Kathuria S; Singh PK; Sharma C; Prakash A; Masih A; Kumar A; Meis JF; Chowdhary A
    J Clin Microbiol; 2015 Jun; 53(6):1823-30. PubMed ID: 25809970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reclassification of the Candida haemulonii complex as Candida haemulonii (C. haemulonii group I), C. duobushaemulonii sp. nov. (C. haemulonii group II), and C. haemulonii var. vulnera var. nov.: three multiresistant human pathogenic yeasts.
    Cendejas-Bueno E; Kolecka A; Alastruey-Izquierdo A; Theelen B; Groenewald M; Kostrzewa M; Cuenca-Estrella M; Gómez-López A; Boekhout T
    J Clin Microbiol; 2012 Nov; 50(11):3641-51. PubMed ID: 22952266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the potential virulence of Candida haemulonii species complex and Candida auris isolates in Caenorhabditis elegans as an in vivo model and correlation to their biofilm production capacity.
    Lima SL; Rossato L; Salles de Azevedo Melo A
    Microb Pathog; 2020 Nov; 148():104461. PubMed ID: 32835773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing prevalence, molecular characterization and antifungal drug susceptibility of serial Candida auris isolates in Kuwait.
    Khan Z; Ahmad S; Al-Sweih N; Joseph L; Alfouzan W; Asadzadeh M
    PLoS One; 2018; 13(4):e0195743. PubMed ID: 29630658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Candida haemulonii Complex Species, Brazil, January 2010-March 2015.
    de Almeida JN; Assy JG; Levin AS; Del Negro GM; Giudice MC; Tringoni MP; Thomaz DY; Motta AL; Abdala E; Pierroti LC; Strabelli T; Munhoz AL; Rossi F; Benard G
    Emerg Infect Dis; 2016 Mar; 22(3):561-3. PubMed ID: 26891028
    [No Abstract]   [Full Text] [Related]  

  • 8. Primary deep cutaneous candidiasis caused by Candida duobushaemulonii in a 68-year-old man: the first case report and literature review.
    Fang SY; Wei KC; Chen WC; Lee SJ; Yang KC; Wu CS; Sun PL
    Mycoses; 2016 Dec; 59(12):818-821. PubMed ID: 27600646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secreted aspartyl peptidases by the emerging, opportunistic and multidrug-resistant fungal pathogens comprising the Candida haemulonii complex.
    Ramos LS; Oliveira SSC; Braga-Silva LA; Branquinha MH; Santos ALS
    Fungal Biol; 2020 Aug; 124(8):700-707. PubMed ID: 32690251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simple low cost differentiation of Candida auris from Candida haemulonii complex using CHROMagar Candida medium supplemented with Pal's medium.
    Kumar A; Sachu A; Mohan K; Vinod V; Dinesh K; Karim S
    Rev Iberoam Micol; 2017; 34(2):109-111. PubMed ID: 28392225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virulence of Candida haemulonii complex in Galleria mellonella and efficacy of classical antifungal drugs: a comparative study with other clinically relevant non-albicans Candida species.
    Silva LN; Campos-Silva R; Ramos LS; Trentin DS; Macedo AJ; Branquinha MH; Santos ALS
    FEMS Yeast Res; 2018 Nov; 18(7):. PubMed ID: 30052907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and Antifungal Susceptibility Profiles of Candida haemulonii Species Complex Clinical Isolates from a Multicenter Study in China.
    Hou X; Xiao M; Chen SC; Wang H; Cheng JW; Chen XX; Xu ZP; Fan X; Kong F; Xu YC
    J Clin Microbiol; 2016 Nov; 54(11):2676-2680. PubMed ID: 27535688
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Jurado-Martín I; Marcos-Arias C; Tamayo E; Guridi A; de Groot PWJ; Quindós G; Eraso E
    J Fungi (Basel); 2020 Dec; 6(4):. PubMed ID: 33348882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Candida haemulonii and closely related species at 5 university hospitals in Korea: identification, antifungal susceptibility, and clinical features.
    Kim MN; Shin JH; Sung H; Lee K; Kim EC; Ryoo N; Lee JS; Jung SI; Park KH; Kee SJ; Kim SH; Shin MG; Suh SP; Ryang DW
    Clin Infect Dis; 2009 Mar; 48(6):e57-61. PubMed ID: 19193113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging Multidrug-Resistant Candida duobushaemulonii Infections in Panama Hospitals: Importance of Laboratory Surveillance and Accurate Identification.
    Ramos R; Caceres DH; Perez M; Garcia N; Castillo W; Santiago E; Borace J; Lockhart SR; Berkow EL; Hayer L; Espinosa-Bode A; Moreno J; Jackson BR; Moran J; Chiller T; de Villarreal G; Sosa N; ; Vallabhaneni S
    J Clin Microbiol; 2018 Jul; 56(7):. PubMed ID: 29695521
    [No Abstract]   [Full Text] [Related]  

  • 16. Transient fungemia caused by an amphotericin B-resistant isolate of Candida haemulonii.
    Rodero L; Cuenca-Estrella M; Córdoba S; Cahn P; Davel G; Kaufman S; Guelfand L; Rodríguez-Tudela JL
    J Clin Microbiol; 2002 Jun; 40(6):2266-9. PubMed ID: 12037106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First Genome Sequences of Two Multidrug-Resistant
    Rodrigues LS; Gazara RK; Passarelli-Araujo H; Valengo AE; Pontes PVM; Nunes-da-Fonseca R; de Souza RF; Venancio TM; Dalla-Costa LM
    Front Microbiol; 2020; 11():1535. PubMed ID: 32719671
    [No Abstract]   [Full Text] [Related]  

  • 18. Multidrug-Resistant Candida haemulonii and C. auris, Tel Aviv, Israel.
    Ben-Ami R; Berman J; Novikov A; Bash E; Shachor-Meyouhas Y; Zakin S; Maor Y; Tarabia J; Schechner V; Adler A; Finn T
    Emerg Infect Dis; 2017 Feb; 23(1):195-203. PubMed ID: 28098529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surface, adhesiveness and virulence aspects of Candida haemulonii species complex.
    Ramos LS; Oliveira SSC; Silva LN; Granato MQ; Gonçalves DS; Frases S; Seabra SH; Macedo AJ; Kneipp LF; Branquinha MH; Santos ALS
    Med Mycol; 2020 Oct; 58(7):973-986. PubMed ID: 31989170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Candida duobushaemulonii: an emerging rare pathogenic yeast isolated from recurrent vulvovaginal candidiasis in Brazil.
    Boatto HF; Cavalcanti SD; Del Negro GM; Girão MJ; Francisco EC; Ishida K; Gompertz OF
    Mem Inst Oswaldo Cruz; 2016 Jun; 111(6):407-10. PubMed ID: 27304096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.